Form 8-K - Current report:
SEC Accession No. 0001104659-25-033797
Filing Date
2025-04-10
Accepted
2025-04-10 16:49:46
Documents
48
Period of Report
2025-04-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512000d1_8k.htm   iXBRL 8-K 31191
2 EXHIBIT 99.1 tm2512000d1_ex99-1.htm EX-99.1 20550
3 EXHIBIT 99.2 tm2512000d1_ex99-2.htm EX-99.2 46496
7 GRAPHIC tm2512000d1_ex99-1img001.jpg GRAPHIC 2833
8 GRAPHIC tm251200d1_ex99-2img001.jpg GRAPHIC 85081
9 GRAPHIC tm251200d1_ex99-2img002.jpg GRAPHIC 417959
10 GRAPHIC tm251200d1_ex99-2img003.jpg GRAPHIC 205508
11 GRAPHIC tm251200d1_ex99-2img004.jpg GRAPHIC 159238
12 GRAPHIC tm251200d1_ex99-2img005.jpg GRAPHIC 214988
13 GRAPHIC tm251200d1_ex99-2img006.jpg GRAPHIC 122156
14 GRAPHIC tm251200d1_ex99-2img007.jpg GRAPHIC 83031
15 GRAPHIC tm251200d1_ex99-2img008.jpg GRAPHIC 176100
16 GRAPHIC tm251200d1_ex99-2img009.jpg GRAPHIC 213079
17 GRAPHIC tm251200d1_ex99-2img010.jpg GRAPHIC 204615
18 GRAPHIC tm251200d1_ex99-2img011.jpg GRAPHIC 161664
19 GRAPHIC tm251200d1_ex99-2img012.jpg GRAPHIC 101063
20 GRAPHIC tm251200d1_ex99-2img014.jpg GRAPHIC 108619
21 GRAPHIC tm251200d1_ex99-2img015.jpg GRAPHIC 119117
22 GRAPHIC tm251200d1_ex99-2img016.jpg GRAPHIC 169647
23 GRAPHIC tm251200d1_ex99-2img017.jpg GRAPHIC 185698
24 GRAPHIC tm251200d1_ex99-2img018.jpg GRAPHIC 142576
25 GRAPHIC tm251200d1_ex99-2img019.jpg GRAPHIC 100332
26 GRAPHIC tm251200d1_ex99-2img020.jpg GRAPHIC 184461
27 GRAPHIC tm251200d1_ex99-2img021.jpg GRAPHIC 212906
28 GRAPHIC tm251200d1_ex99-2img022.jpg GRAPHIC 214002
29 GRAPHIC tm251200d1_ex99-2img023.jpg GRAPHIC 177382
30 GRAPHIC tm251200d1_ex99-2img024.jpg GRAPHIC 177189
31 GRAPHIC tm251200d1_ex99-2img025.jpg GRAPHIC 201826
32 GRAPHIC tm251200d1_ex99-2img026.jpg GRAPHIC 139795
33 GRAPHIC tm251200d1_ex99-2img027.jpg GRAPHIC 254770
34 GRAPHIC tm251200d1_ex99-2img028.jpg GRAPHIC 168873
35 GRAPHIC tm251200d1_ex99-2img029.jpg GRAPHIC 191168
36 GRAPHIC tm251200d1_ex99-2img031.jpg GRAPHIC 162280
37 GRAPHIC tm251200d1_ex99-2img032.jpg GRAPHIC 183907
38 GRAPHIC tm251200d1_ex99-2img033.jpg GRAPHIC 102944
39 GRAPHIC tm251200d1_ex99-2img034.jpg GRAPHIC 61210
  Complete submission text file 0001104659-25-033797.txt   7749343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ganx-20250410.xsd EX-101.SCH 3038
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20250410_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20250410_pre.xml EX-101.PRE 22374
50 EXTRACTED XBRL INSTANCE DOCUMENT tm2512000d1_8k_htm.xml XML 3800
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 25829025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)